163 related articles for article (PubMed ID: 22939953)
1. Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma.
Luo Y; Qiu Z; Tian L; Zhu G; Feng Y; Yi M; Chen X; Wang L; Li C; Huang Q
Hum Pathol; 2013 Jan; 44(1):69-76. PubMed ID: 22939953
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
Dancer J; Takei H; Ro JY; Lowery-Nordberg M
Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
4. Correlation between different p53 expression patterns and chromosome 17 imbalances in pancreatic ductal adenocarcinoma based on tissue microarray analysis.
Tsiambas E; Kravvaritis C; Tsounis D; Salemis NS; Niotis A; Niotis TH; Rigopoulos DN; Karameris A; Athanasiou AE; Patsouris E; Karakitsos P
J BUON; 2010; 15(1):94-100. PubMed ID: 20414934
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of topoisomerase IIa expression in pancreatic ductal adenocarcinoma: a pilot study using chromogenic in situ hybridization and immunohistochemistry on tissue microarrays.
Tsiambas E; Karameris A; Tiniakos DG; Karakitsos P
Pancreatology; 2007; 7(1):45-52. PubMed ID: 17449965
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.
Valsecchi ME; McDonald M; Brody JR; Hyslop T; Freydin B; Yeo CJ; Solomides C; Peiper SC; Witkiewicz AK
Cancer; 2012 Jul; 118(14):3484-93. PubMed ID: 22086503
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and immunohistochemistry.
Bachmann K; Neumann A; Hinsch A; Nentwich MF; El Gammal AT; Vashist Y; Perez D; Bockhorn M; Izbicki JR; Mann O
J Surg Oncol; 2015 Mar; 111(3):316-23. PubMed ID: 25470788
[TBL] [Abstract][Full Text] [Related]
8. Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1).
Hermanová M; Lukás Z; Nenutil R; Brázdil J; Kroupová I; Kren L; Pazourková M; Růzicka M; Díte P
Neoplasma; 2004; 51(2):77-83. PubMed ID: 15190415
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder.
Shafizadeh N; Grenert JP; Sahai V; Kakar S
Hum Pathol; 2010 Apr; 41(4):485-92. PubMed ID: 20040392
[TBL] [Abstract][Full Text] [Related]
11. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
[TBL] [Abstract][Full Text] [Related]
12. The predictive role of p16 deletion, p53 deletion, and polysomy 9 and 17 in pancreatic ductal adenocarcinoma.
Luo Y; Tian L; Feng Y; Yi M; Chen X; Huang Q
Pathol Oncol Res; 2013 Jan; 19(1):35-40. PubMed ID: 22782330
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays.
Tsiambas E; Karameris A; Gourgiotis S; Salemis N; Athanassiou AE; Karakitsos P; Papalois A; Merikas E; Kosmidis P; Patsouris E
J BUON; 2007; 12(2):261-7. PubMed ID: 17600882
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
15. Human pancreatic ribonuclease 1: expression and distribution in pancreatic adenocarcinoma.
Peracaula R; Cleary KR; Lorenzo J; de Llorens R; Frazier ML
Cancer; 2000 Sep; 89(6):1252-8. PubMed ID: 11002220
[TBL] [Abstract][Full Text] [Related]
16. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of epidermal growth factor receptor (EGFR) alterations in human pancreatic tumors.
Lozano-Leon A; Perez-Quintela BV; Iglesias-García J; Urisarri-Ruiz A; Lariño-Noia J; Abdulkader I; Varo E; Forteza J; Domínguez-Muñoz JE
Oncol Rep; 2011 Aug; 26(2):315-20. PubMed ID: 21573507
[TBL] [Abstract][Full Text] [Related]
18. EGFR alterations in pancreatic ductal adenocarcinoma: a chromogenic in situ hybridization analysis based on tissue microarrays.
Tsiambas E; Karameris A; Lazaris AC; Talieri M; Triantafillidis JK; Cheracakis P; Manaios L; Gerontopoulos K; Patsouris E; Lygidakis NJ
Hepatogastroenterology; 2006; 53(69):452-7. PubMed ID: 16795991
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis.
Tobita K; Kijima H; Dowaki S; Kashiwagi H; Ohtani Y; Oida Y; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2003 Mar; 11(3):305-9. PubMed ID: 12579331
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of thymidine phosphorylase expression for pancreatic cancer.
Hong SP; Shin SK; Bang S; Park SW; Chung JB; Lee WJ; Song SY
Hepatogastroenterology; 2009; 56(93):1178-82. PubMed ID: 19760965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
